ArticleDrug design, development and therapy2015

Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center.

Mehran Afshar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.